Benesch represented La Lumiere in its closing of a $20 million Series B financing. The investment included Johnson & Johnson Development Corporation (Johnson & Johnson’s venture capital subsidiary), joined by SWaN & Legend Venture Partners as institutional investors in the company.
La Lumiere was founded on bringing innovations to the market for at-home beauty treatments. As a leader in an emerging field of wearable light therapy devices, La Lumiere has two products currently on the market: one for anti-aging and the other for anti-acne.
The Benesch team was led by Megan L. Mehalko and included Jessica N. Angney.
Latest News
Benesch Recognized as Leading Law Firm by Chambers USA 2026 with Record Growth in National and Regional Rankings
Benesch has once again been recognized by Chambers and Partners as one of the nation’s leading law firms in its Chambers USA 2026 guide, with 43 Benesch attorneys and 21 practice areas ranked.
Benesch Government Relations Partner Holly Gross Named a 2026 Women of Influence by Columbus Business First
Benesch is pleased to announce that Government Relations Partner Holly Gross has been named among Columbus Business First’s 2026 Women of Influence in the Trailblazer category. This recognition honors women who are pioneers or firsts in their field and who have broken new ground, opened doors for others or led innovation in industries where women may be underrepresented.
Benesch Represents Tribeca Strategic Acquisition Corporation in $140 Million Public Offering
Benesch represented Tribeca Strategic Acquisition Corporation (Nasdaq: BIDWU) in its $140 million initial public offering on the Nasdaq Global Market. …
Benesch Named Recipient of AHLA 2026 Top Honors for Sixth Consecutive Year
Benesch is pleased to announce that it has been named a recipient of the American Health Law Association’s (AHLA) 2026 …